Assyro AI

Orange Book product · Generic (ANDA)

RIFABUTIN

RIFABUTIN

Generic (ANDA)ANDA 090033DISCN LUPIN

At a glance

Feb 24, 2014

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 24, 2014

    12 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

RIFABUTIN

Strength

150MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 090033

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of RIFABUTIN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.